Increased expression and dysregulated association of restriction factors and type I interferon in HIV, HCV mono- and co-infected patients

被引:12
作者
Zhu, Jia-Wu [1 ,2 ]
Liu, Feng-Liang [1 ]
Mu, Dan [1 ,2 ]
Deng, De-Yao [3 ]
Zheng, Yong-Tang [1 ,2 ]
机构
[1] Chinese Acad Sci, Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China
[2] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Yunnan, Peoples R China
[3] Second Peoples Hosp Yunnan Prov, Dept Clin Lab, Kunming, Yunnan, Peoples R China
基金
中国国家自然科学基金;
关键词
HIV; HCV; co-infection; restriction factors; type I interferon; MESSENGER-RNA LEVELS; CHRONIC HEPATITIS-C; VIRUS-INFECTION; DISEASE PROGRESSION; APOBEC3G; GENE; TRIM5-ALPHA; COINFECTION; LIVER; REPLICATION;
D O I
10.1002/jmv.24419
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Host restriction factors and type I interferon are important in limiting HIV and HCV infections, yet the role of HIV, HCV mono- and co-infection in regulating these antiviral genes expression is not clear. In this study, we measured the levels of TRIM5, TRIM22, APOBEC3G, and IFN-, - mRNA expression in peripheral blood mononuclear cells of 43 HIV mono-infected, 70 HCV mono-infected and 64 HIV/HCV co-infected patients along with 98 healthy controls. We also quantified HIV and HCV viral loads in mono- and co-infected patients. The results showed that HCV, HIV mono- and co-infection differentially increased TRIM22, APOBEC3G, and IFN-, - mRNA expression while the mRNA expression of TRIM was upregulated only by HCV-mono infection. HIV/HCV co-infection was associated with higher viral load, compared to either HIV or HCV mono-infection. Additionally, we showed TRIM and TRIM22 positively correlated with IFN-, -, which could be dysregulated by HIV, HCV mono- and co-infection. Furthermore, we found TRIM22 negatively correlated with HCV viral load in mono-infected patients and APOBEC3G positively correlated with HCV viral load in co-infected patients. Collectively, our findings suggest the potential role of restriction factors in restricting HIV, HCV mono- and co-infection in vivo, which appears to be a therapeutic target for potential drug discovery. J. Med. Virol. 88:987-995, 2016. (c) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:987 / 995
页数:9
相关论文
共 46 条
  • [1] Higher levels of hepatitis C virus RNA found in blood donors co-infected with HIV as compared to HCV mono-infected donors
    Alidjinou, Enagnon Kazali
    Moukassa, Donatien
    Ebatetou-Ataboho, Eben
    Mahoungou, Gael Honal
    Pambou, Jean-Paul
    Sane, Famara
    Prevost, Brigitte
    Bocket, Laurence
    Ibara, Jean-Rosaire
    Hober, Didier
    [J]. JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2014, 8 (08): : 1068 - 1071
  • [2] A retrovirus restriction factor TRIM5α is transcriptionally regulated by interferons
    Asaoka, K
    Ikeda, K
    Hishinuma, T
    Horie-Inoue, K
    Takeda, S
    Inoue, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 338 (04) : 1950 - 1956
  • [3] The interferon response inhibits HIV particle production by induction of TRIM22
    Barr, Stephen D.
    Smiley, James R.
    Bushman, Frederic D.
    [J]. PLOS PATHOGENS, 2008, 4 (02)
  • [4] Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: A possible role in the resistance to HIV of HIV-exposed seronegative individuals
    Biasin, Mara
    Piacentini, Luca
    Lo Caputo, Sergio
    Kanari, Yasuyoshi
    Magri, Giuliana
    Trabattoni, Daria
    Naddeo, Valentina
    Lopalco, Lucia
    Clivio, Alberto
    Cesana, Eugenio
    Fasano, Francesca
    Bergamaschi, Cristina
    Mazzotta, Francesco
    Miyazawa, Masaaki
    Clerici, Mario
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (07) : 960 - 964
  • [5] APOBEC3F and APOBEC3G mRNA levels do not correlate with human immunodeficiency virus type 1 plasma viremia or CD4+ T-cell count
    Cho, SJ
    Drechsler, H
    Burke, RC
    Arens, MQ
    Powderly, W
    Davidson, NO
    [J]. JOURNAL OF VIROLOGY, 2006, 80 (04) : 2069 - 2072
  • [6] Coppola Nicola, 2015, World J Virol, V4, P1, DOI 10.5501/wjv.v4.i1.1
  • [7] Human immunodeficiency virus type 1 Vpr increases hepatitis C virus RNA replication in cell culture
    Deng, Amei
    Chen, Chao
    Ishizaka, Yukihito
    Chen, Xinwen
    Sun, Binlian
    Yang, Rongge
    [J]. VIRUS RESEARCH, 2014, 184 : 93 - 102
  • [8] Emerging treatments for hepatitis C
    Flisiak, Robert
    Jaroszewicz, Jerzy
    Parfieniuk-Kowerda, Anna
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2013, 18 (04) : 461 - 475
  • [9] ENCODE Tiling Array Analysis Identifies Differentially Expressed Annotated and Novel 5′ Capped RNAs in Hepatitis C Infected Liver
    Folkers, Milan E.
    Delker, Don A.
    Maxwell, Christopher I.
    Nelson, Cassie A.
    Schwartz, Jason J.
    Nix, David A.
    Hagedorn, Curt H.
    [J]. PLOS ONE, 2011, 6 (02):
  • [10] Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus
    Gentile, Ivan
    Coppola, Nicola
    Buonomo, Antonio Riccardo
    Zappulo, Emanuela
    Borgia, Guglielmo
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (09) : 1211 - 1223